age-related macular degeneration (AMD)

Stem cell trial aims to cure AMD
Stem cell trial aims to cure AMDThe London Project to Cure Blindness announced it successfully performed a surgery to transplant retinal pigment epithelium (RPE) derived from stem cells into a patient suffering from vision loss from wet age-related macular degeneration (AMD).
Home monitoring for AMD may have substantial impact on U.S. public healthUse of a home monitoring device to monitor patients at high risk for wet age-related macular degeneration may have a considerable public health impact over time.
Bad blue light, macular pigment, and prescriptive carotenoidsOur sun, modern indoor blue LED lighting, cell phones, and computer displays all emit “bad blue” radiation defined as a wavelength band of 435 nm ± 20 nm.
Bone marrow cells show promise in degenerative, ischemic retinal diseasesThe safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective study with longer follow-up.